Insider Trading & Ownership - Fitzgerald Kevin Joseph

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fitzgerald Kevin Joseph
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-26
Sale
2024-11-27
5:20 pm
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
3,000$251.65$754,94713,418
(Indirect
Direct)
View
2024-08-12
Sale
2024-08-14
4:12 pm
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
22,025$270.99$5,968,51615,610
(Indirect
Direct)
View
2024-06-25
Sale
2024-06-26
4:26 pm
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
1,198$230.99$276,73114,718
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-12-12
Option Award
2024-12-16
4:15 pm
N/A
2034-12-11
Ovid Therapeutics Inc.OVIDFitzgerald Kevin Joseph
Director
90,000$090,000
(Direct)
View
2024-11-25
Option Award
2024-11-27
5:20 pm
N/A
N/A
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
3,000$013,418
(Direct)
View
2024-08-12
Exercise
2024-08-14
4:12 pm
N/A
N/A
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
6,667$97.7215,610
(Direct)
View
2024-08-12
Exercise
2024-08-14
4:12 pm
N/A
2029-02-28
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
20,725$015,610
(Direct)
View
2024-08-12
Exercise
2024-08-14
4:12 pm
N/A
N/A
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
14,058$8515,610
(Direct)
View
2024-06-24
Option Award
2024-06-26
4:26 pm
N/A
N/A
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
2,498$014,718
(Direct)
View

Ownership
2024-03-28
4:17 pm
N/A
N/A
ALNYLAM PHARMACEUTICALS INC.ALNYFitzgerald Kevin Joseph
CSO & EVP, Head of Research
0$0124,620
(Direct)
View
2024-02-22
Option Award
2024-02-26
5:56 pm
N/A
2034-02-21
Ovid Therapeutics Inc.OVIDFitzgerald Kevin Joseph
Director
30,000$030,000
(Direct)
View
2023-02-23
Option Award
2023-02-27
4:51 pm
N/A
2033-02-22
Ovid Therapeutics Inc.OVIDFitzgerald Kevin Joseph
Director
15,000$015,000
(Direct)
View
2022-02-03
Option Award
2022-02-04
8:49 pm
N/A
2032-02-02
Ovid Therapeutics Inc.OVIDFitzgerald Kevin Joseph
Director
15,000$015,000
(Direct)
View
2021-10-06
Option Award
2021-10-07
4:44 pm
N/A
2031-10-05
Ovid Therapeutics Inc.OVIDFitzgerald Kevin Joseph
Director
30,000$030,000
(Direct)
View